Circulation Journal Report DALLAS, April 1, 2019 -- A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander CPR nearly doubled; compression-only (or...
Credit: Tae Hyun Kim ANN ARBOR, Michigan -- A prototype wearable device, tested in animal models, can continuously collect live cancer cells directly from a...
FAIR Health market indices and trending reports once again bring valuable visibility into patient migratory patterns and healthcare costs NEW YORK, NY--April 1, 2019--From 2016...
Credit: © 2019 AANS CHARLOTTESVILLE, VA (APRIL 1, 2019). The April issue of Neurosurgical Focus (thejns.org/toc/foc/46/4) contains 15 new articles on the principles of enhanced...
All brisk walking, even short walks, help prevent disability in older adults with osteoarthritis CHICAGO --- Just one hour a week of brisk walking --...
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (April 1, 2019) - When a breast cancer tumor is removed with no signs of cancer...
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial. (PHILADELPHIA) - Glioblastoma is the most...
Study results to be presented during a plenary session at AACR Annual Meeting ATLANTA - A new combination of immunotherapy and chemotherapy for pancreatic cancer...
ATLANTA --Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk than excess weight at older ages, according to results...
Computational tools seek to identify pancreatic cancer earlier, provide more opportunities for timely, effective treatmentsCredit: Pancreatic Cancer Collective (ATLANTA - March 30, 2019) - The...
Credit: Hope Foundation for Cancer Research A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to new research results presented at...
ATLANTA -- Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who had EGFR-mutant non-small cell lung...
ATLANTA -- A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit among patients with rare, high-grade neuroendocrine...
ATLANTA -- A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was found to be safe and...
ATLANTA -- A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity and had antitumor activity in...
